title: Onyx resorbtion with AVM recanalization after complete AVM obliteration.
abstract: Brain arteriovenous malformations (BAVM) are some of the most complex lesions treated by clinical neuroscientists. The recent publication of the ARUBA trial, showing higher complication rates with treatment compared with the natural history over a short period of follow-up, puts even more pressure on the physician to achieve complete BAVM eradication without complication. These lesions are often treated by multimodality therapy with some combination of endovascular embolization, radiosurgery, and microsurgical resection; however, multimodality therapy involves the additive risk of procedural complication with each procedure. While surgical resection has long been accepted as monotherapy with good cure rates, staged pre-operative endovascular embolization has facilitated microsurgical resection with lower blood loss. Endovascular embolization is more often utilized in conjunction with surgical resection, and often the portions of the AVM and feeders that are completely embolized with Onyx or glue may not be surgically resected since they have been "internally obliterated." We present a case where the AVM was preoperatively embolized with Onyx and subsequently partially surgically resected. Post-operative angiography showed complete obliteration or "cure" of the AVM with no filling of the nidus or early venous drainage. The patient presented 12 months later with seizures and imaging showed volume loss in the residual Onyx cast and recanalization of the AVM nidus. The patient subsequently underwent repeat resection with complete removal of the residual AVM and Onyx cast. To our knowledge this is the first published report of volume loss within the Onyx cast leading to recanalization of the AVM nidus. This suggests that extreme care should be taken with partial resection of the AVM nidus or with embolization for cure, as late recanalization may occur.
authors.affiliation: Cerebrovascular Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA bauera3@ccf.org.
authors.forename: Andrew M
authors.initials: AM
authors.lastname: Bauer
authors.affiliation: Cerebrovascular Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.
authors.forename: Mark D
authors.initials: MD
authors.lastname: Bain
authors.affiliation: Cerebrovascular Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.
authors.forename: Peter A
authors.initials: PA
authors.lastname: Rasmussen
mesh_terms: D015901:Angiography, Digital Subtraction; D002533:Cerebral Angiography; D002648:Child; D004121:Dimethyl Sulfoxide / Q000627:therapeutic use*; D004621:Embolization, Therapeutic / Q000379:methods*; D005260:Female; D005471:Fluoroscopy; D006801:Humans; D002538:Intracranial Arteriovenous Malformations / Q000628:therapy*; D008279:Magnetic Resonance Imaging; D011145:Polyvinyls / Q000627:therapeutic use*
chemical_list: C450660:Onyx copolymer; D011145:Polyvinyls; D004121:Dimethyl Sulfoxide
keywords: Brain arteriovenous malformations; Onyx copolymer; intracranial AVM; therapeutic embolization